5462-13-5

Basic information

• Product Name: 3-(2-METHOXY-PHENYL)-PROPIONIC ACID ETHYL ESTER
• Synonyms: ethyl 3-(3,4-dimethoxyphenyl)propanoate
• CAS NO: 5462-13-5
• Molecular Formula: C₁₃H₁₈O₄
• Molecular Weight: 208.25
• Mol File: 5462-13-5.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 320.1°C at 760 mmHg
• Flash Point: 137.6°C
• Appearance: /
• Density: 1.067g/cm³
• Vapor Pressure: 0.000325mmHg at 25°C
• Refractive Index: 1.492
• CAS DataBase Reference: 3-(2-METHOXY-PHENYL)-PROPIONIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2-METHOXY-PHENYL)-PROPIONIC ACID ETHYL ESTER(5462-13-5)
• EPA Substance Registry System: 3-(2-METHOXY-PHENYL)-PROPIONIC ACID ETHYL ESTER(5462-13-5)

Safety Data

• Hazardous Substances Data: 5462-13-5(Hazardous Substances Data)

Usage

General Description

3-(2-Methoxy-phenyl)-propionic acid ethyl ester is a compound with the chemical formula C12H16O3. It is a derivative of propionic acid and contains a phenyl ring with a methoxy group attached to it. This chemical is used as an esterifying reagent in organic synthesis and as a fragrance ingredient in the production of perfumes and other scented products. It may also have potential applications in the pharmaceutical industry due to its structural similarity to other compounds with known biological activities. Additionally, research is ongoing to explore its potential use in the development of novel drugs or materials.

InChI:InChI=1/C13H18O4/c1-4-17-13(14)8-6-10-5-7-11(15-2)12(9-10)16-3/h5,7,9H,4,6,8H2,1-3H3

Upstream product

• 64-17-5 ethanol 
• 20583-78-2 ethyl (E)-3,4-dimethoxycinnamate 
• 20583-78-2 3,4-dimethoxy-cinnamic acid ethyl ester 
• 2033-24-1 cycl-isopropylidene malonate 
• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 144918-21-8 ethyl 2-bromo-3-(3,4-dimethoxyphenyl)-3-(prop-2-ynyloxy)propanoate 
• 2316-26-9 3,4-dimethoxycinnamic acid 
• 2107-70-2 3,4-methoxycinnamic acid 

Downstream Products

• 2107-70-2 3,4-methoxycinnamic acid 
• 118156-83-5 3-(3,4-dimethoxyphenyl)-1-iodopropane 
• 110406-97-8 4-(4-chloropropyl)-1,2-dimethoxybenzene 
• 1160923-82-9 5-(3,4-dimethoxyphenyl)-3-oxopentanonitrile 
• 54537-74-5 5-(3,4-Dimethoxy-phenyl)-2-methanesulfinyl-3-oxo-pentanoic acid phenylamide 
• 54537-79-0 Dichloro-acetic acid 4-(3,4-dimethoxy-phenyl)-1-methylsulfanyl-2-oxo-butyl ester 
• 54537-73-4 6-(3,4-Dimethoxy-phenyl)-3-methanesulfinyl-4-oxo-hexanoic acid methyl ester 
• 102598-22-1 2,5-bis-(3,4-dimethoxy-phenyl)-3-oxo-valeric acid amide 
• 854657-64-0 5-(3,4-dimethoxy-phenyl)-3-oxo-2-phenyl-valeric acid amide 
• 107627-10-1 4-(3,4-dimethoxyphenyl)-1-phenylbutan-2-one 
• 21997-97-7 3-(3,4-dimethoxy-phenyl)-propionyl azide 
• 20716-22-7 3-(4,5-dimethoxy-2-nitrophenyl)propan-1-ol 
• 94773-83-8 [1-(3,4-Dimethoxy-benzyl)-but-3-enylcarbamoyloxy]-acetic acid ethyl ester 
• 70311-32-9 2-[2-(5-methyl-4-imidazolylmethylthio)ethylamino]-5-(3,4-dimethoxybenzyl)-4-pyrimidone dihydrochloride 

Relevant articles and documents

Catalytic cyclization of propargyl bromoethers via electrogenerated nickel(I) tetramethylcyclam in ionic liquids: Water effects

Cyclic voltammetry and controlled-potential electrolysis have been employed to investigate the reductive intramolecular cyclization of propargyl bromoethers derivatives, catalyzed by electrogenerated (1,4,8,11-tetramethyl-1,4,8,11-tetraaza-cyclotetradecan

Concise synthesis of the vasorelaxant alkaloids schwarzinicines A and B

A concise synthesis of the 1,4-diarylbutanoid–phenethylamine alkaloids, schwarzinicines A (1) and B (2), recently isolated from Ficus schwarzii, is reported. Key steps include a Claisen condensation to assemble the 1,4-diaryl-2-butanone intermediate, foll

Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase

1-Deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) in the non-mevalonate pathway found in most bacteria is a validated anti-infective drug target. Fosmidomycin, a potent DXR inhibitor, is active against Gram-negative bacteria. A coordination chemistry and structure based approach was used to discover a novel, lipophilic DXR inhibitor with an IC50 of 1.4 μM. It exhibited a broad spectrum of activity against Gram-negative and -positive bacteria with minimal inhibition concentrations of 20-100 μM (or 3.7-19 μg/mL).